These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5885215)

  • 1. I. Evidence that a hypercoagulable state precedes massive oozing during and after major surgery. II. Effect of epsilon-aminocaproic acid (EACA) in control of surgical oozing.
    Cliffton EE
    Bibl Haematol; 1965; 23():1264-77. PubMed ID: 5885215
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of epsilon aminocaproic acid on the blood loss after retropubic prostatectomy.
    Lawrence AC; Ward-McQuaid JN
    Br J Urol; 1966 Jun; 38(3):308-10. PubMed ID: 4161415
    [No Abstract]   [Full Text] [Related]  

  • 3. Epsilon-aminocaproic acid (EACA).
    Griffin JD; Ellman L
    Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological fibrinolytic states and their treatment with epsilon aminocaproic acid (EACA).
    McNicol GP; Browne MK; Bayley C; Douglas AS
    Br J Surg; 1966 Jan; 53(1):26-9. PubMed ID: 5901909
    [No Abstract]   [Full Text] [Related]  

  • 5. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACID].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M
    Hemostase; 1964 Mar; 4():95-101. PubMed ID: 14188681
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 7. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current clotting concepts in urology.
    Kursh ED; Ratnoff OD; Persky L
    J Urol; 1976 Aug; 116(2):214-7. PubMed ID: 950707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolysis in congenital heart disease. Preoperative treatment with epsilon-aminocaproic acid.
    Brodsky I; Gill DN; Lusch CJ
    Am J Clin Pathol; 1969 Jan; 51(1):51-7. PubMed ID: 5766110
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA; Roach RW
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE USE OF THE SERIAL THROMBIN TIME IN EVALUATING THERAPY WITH EPSILON AMINOCAPROIC ACID IN MASSIVE THROMBOLYSIS AND PROTEOLYSIS.
    BRODSKY I; ROSS E; REID WO
    Am J Clin Pathol; 1964 Jun; 41():589-96. PubMed ID: 14183048
    [No Abstract]   [Full Text] [Related]  

  • 13. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
    SWEENEY WM
    Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amniotic fluid embolism. A case investigated by coagulation and fibrinolysis studies.
    Skjodt P
    Acta Obstet Gynecol Scand; 1965; 44(3):437-57. PubMed ID: 5863077
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of epsilon-aminocaproic acid on the mineralocorticoid hypertension of the rat.
    Hartig F; Sponer G; Bartsch W; von Möllendorf E
    Exp Pathol; 1981; 19(4):199-205. PubMed ID: 7250299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 18. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.
    MCNICOL GP; DOUGLAS AS
    Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764
    [No Abstract]   [Full Text] [Related]  

  • 19. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 20. Epsilon-aminocaproic acid for synovectomy in haemophilic patients.
    Storti E; Ascari E; Turpini R; Molinari E; Gamba G; Pettene A
    Acta Haematol; 1972; 47(3):146-56. PubMed ID: 4624252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.